This grand round has already taken place.
Discussion of the various relationships between cannabis and psychosis disorders.
Dates and Times
Start: 12/3/2019 11:00 AM
End: 12/3/2019 12:00 PM
There is a growing movement across the U.S. legalizing the medical and recreational use of marijuana (cannabis). Medical cannabis has been approved for a number of psychiatric conditions. Exposure to cannabis may be associated with a number of neuropsychiatric consequences. Converging lines of evidence suggest that exposure to cannabis and other cannabinoids might be associated with a range of psychosis outcomes suggesting an exocannabinoid hypothesis. More recent data also suggests endocannabinoid dysfunciton in schizophrenia.
1. Describe the temporal relationships between exposure to cannabinoids and psychosis outcomes
2. Discuss the strengths and limitations of the evidence
3. Discuss the clinical implications of evidence
4. Discuss the endocannabinoid hypothesis
Grand Round Files
References related to Psychiatry & Behavioral Health Grand Rounds of December 3, 2019.
101 Nicolls Road
HSC, T-10, Rm. 026
HSC, Level 3, Lecture Hall 6
Stony Brook, NY 11790
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.